Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide in Metastatic Colorectal Cancer
NCT06049901Phase 3Recruiting
- Sponsor
- Tanta University
- Start
- Mar 2023
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nitazoxanide in colorectal cancer (CRC), sponsored by Tanta University. Started Mar 2023; status: recruiting.
02
Drugs
nitazoxanide
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06049901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06049901.